Study of Recombinant Factor IX Product, IB1001, in Subjects With Hemophilia B
Clinical trial NCT00768287 · COMPLETED
Trial details
- NCT number
- NCT00768287
- Sponsor
- Medexus Pharma, Inc.
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-01-01
- Primary completion
- 2013-03-01
- Enrollment
- 77
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.